The pathophysiology of hepatic encephalopathy

Nursing in Critical Care

Volumn 11, Issue 2, 2006, Pages 69-74

  Faint, Victoria ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Ammonia; Branched chain amino acids; False neurotransmitters; GABA benzodiazipines; Hepatic encephalopathy; Precipitating factors

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; AMMONIA; AROMATIC AMINO ACID; BRANCHED CHAIN AMINO ACID;

BRAIN LEVEL; CLASSIFICATION; EPIDEMIOLOGY; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; INFECTION; KIDNEY DISEASE; METABOLIC DISORDER; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

AMINO ACIDS, AROMATIC; AMINO ACIDS, BRANCHED-CHAIN; AMMONIA; BRAIN CHEMISTRY; GAMMA-AMINOBUTYRIC ACID; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMANS; INFECTION; KIDNEY DISEASES; PRECIPITATING FACTORS; RECEPTORS, GABA-A; SEVERITY OF ILLNESS INDEX; WATER-ELECTROLYTE IMBALANCE;

EID: 33645909107     PISSN: 13621017     EISSN: 14785153     Source Type: Journal    
DOI: 10.1111/j.1362-1017.2006.00149.x     Document Type: Review

References (38)

1. Als-Nielson B, Gluud L, Gluud C. (2004). Nonabsorbable disaccharides for hepatic encephalopathy (Cochrane Review). In:, The Cochrane Review. Issue 3. Chicester, UK: John Wiley & Sons Ltd.
2. Als-Nielson B, Kjaergard LL, Gluud C. (2003). Benzodiazepine receptor antagonists for acute and chronic encephalopathy (Cochrane Review). In:, The Cochrane Library. Issue 4. Chicester, UK: John Wiley & Sons Ltd.
3. Als-Nielson B, Koretz RL, Kjaergard LL, Gluud C. (2003). Branched-chain amino acids for hepatic encephalopathy (Cochrane review). In:, The Cochrane Library. Issue 4. Chicester, UK: John Wiley & Sons Ltd.
4. Amodio P, Marchetti P, Del Piccolo F, Beghi A, Comacchio F, Carraro P, Campo G, Baruzzo L, Marchiori C, Gatta A. (1997). The effect of flumazenil on sub clinical psychometric or neurophysical alterations in cirrhotic patients: a double blind placebo controlled study. Clinical Physiology; 17: 533–539.
5. Apps DK, Cohen BB, Steel CM. (1992). Biochemistry: A Concise Text for Medical Students, 5th edn. London: Ballière-Tindall.
6. Barabaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G. (1998). Flumanzenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double blind, placebo controlled, cross over study. Hepatology; 28: 376–378.
7. Basile AS, Harrison PM, Hughes RD, Gu Z-Q, Pannell L, McKinney A, Jones EA, Williams R. (1993). Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology; 19: 112–121.
8. Basile AS, Jones EA. (1997). Ammonia and GABA-ergic neuro-transmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology; 25: 1303–1305.
9. Blei AT. (1996). Hepatic encephalopathy. In: Kaplowitz N, (ed), Liver and Billiary Diseases, 2nd edn. USA, Williams & Wilkins.
10. Blei A, Olafsson S, Therrien G, Butterworth R. (1994). Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology; 19: 1437–1444.
11. Butterworth RF. (1997). Hepatic encephalopathy and brain edema in acute hepatic failure: does glutamate play a role? Hepatology; 25: 1032–1033.
12. Butterworth R. (2000). Complications of cirrhosis III. Hepatic encephalopathy. Journal of Hepatology; 32: 171–180.
13. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A. (2002). Hepatic encephalopathy – Definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology; 35: 716–721.
14. Gillham B, Papachristodoulou DK, Thomas JH. (1997). Will's Biochemical Basis of Medicine, 3rd edn. Oxford: Butterworth Heinemann.
15. Haussinger D, Kircheis G, Fischer R, Schliess F, Vom Dahl S. (2000). Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low grade cerebral oedema? Journal of Hepatology; 32: 1035–1038.
16. Haussinger D, Schleiss F, Kircheis G. (2002). Pathogenesis of hepatic encephalopathy. Journal of Gastroenterology and Hepatology; 17: S256–S259.
17. Jalan R, Hayes P. (1997). Hepatic encephalopathy and ascites. Lancet; 350: 1309–1315.
18. James JH. (2002). Branched chain amino acids in hepatic encephalopathy. The American Journal of Surgery; 183: 424–429.
19. Kircheis G, Haussinger D. (2002). Management of hepatic encephalopathy. Journal of Gastroenterology and Hepatology; 17: S260–S267.
20. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, Hendricks R, Kruger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rosch W, Stauch S. (1997). Therapeutic effects of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double blind study. Hepatology; 25: 1351–1360.
21. Kramer L, Tribl B, Gendo A, Zanner C, Schneider B, Ferenci P, Madl C. (2000). Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology; 31: 30–34.
22. Krige JEJ, Beckingham IJ. (2001). Portal hypertension-2. Ascites, encephalopathy and other conditions. British Medical Journal; 322: 416–418.
23. Liu Q, Duan Z, Ha D, Bengmark S, Kurtovic J, Riordan S. (2004). Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology; 39: 1441–1449.
24. Loguercio C, Abbiati R, Rinaldi M, Romano A, Del Vecchio Blanco C, Coltorti M. (1995). Long term effects of enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. Journal of Hepatology; 23: 39–46.
25. 3H] 5-Fluorowillardiine in the brains of rats with acute liver failure. Hepatology; 25: 631–635.
26. Michalak A, Rose C, Butterworth J, Butterworth RF. (1996). Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology; 24: 908–913.
27. Mullen KD. (2000). Hepatic encephalopathy. In: O'Grady J, Lake J, Howdle P, (eds), Comprehensive Clinical Hepatology. London: Mosby.
28. Nicolao F, Efrati C, Masini A, Merli M, Attili AF, Riggio O. (2003). Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. Journal of Hepatology; 38: 441–446.
29. Norenberg MD. (1998). Astroglial dysfunction in hepatic encephalopathy. Metabolic Brain Disease; 13: 319–328.
30. Ong J, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, Arroliga AC, Mullen KD. (2003). Correlation between ammonia levels and the severity of hepatic encephalopathy. The American Journal of Medicine; 114: 188–193.
31. Puspok A, Herneth A, Steindl P, Ferenci P. (1993). Hepatic encephalopathy in rats with thiocetamide induced acute liver failure is not mediated by endogenous benzodiazepines. Gastroenterology; 105: 851–857.
32. Riordan SM, Williams R. (1997). Treatment of hepatic encephalopathy. The New England Journal of Medicine; 337: 473–479.
33. Rolando N, Wade J, Davalos M, Wendon J, Phillpott-Howard J, Williams R. (2000). The systemic inflammatory response in acute liver failure. Hepatology; 32: 734–739.
34. Rose C, Michilak A, Pannunzio P, Therrien G, Quack G, Kircheis G, Butterworth RF. (1998). L-ornithine-L-aspartate in experimental portal systemic encephalopathy: therapeutic efficacy and mechanism of action. Metabolic Brain Disease; 13: 147–157.
35. Vaquero J, Chung C, Cahill M, Blei A. (2003). Pathogenesis of hepatic encephalopathy in acute liver failure. Seminars in Liver Disease; 23: 259–269.
36. Voigt M, Conn H. (1995). Hepatic encephalopathy. In: Kirsch R, Robson S, Trey C, (eds), Diagnosis and Management of Liver Disease. London: Chapman & Hall Medical.
37. Widler P, Fisch HU, Schoch P, Zimmermann A, Schlapfer TE, Reichen J. (1993). Increased benzodiazepine like activity is neither necessary or sufficient to explain acute hepatic encephalopathy in the thioacetamide treated rat. Hepatology; 18: 1459–1464.
38. Yurdaydin C. (2003). Blood ammonia determination in cirrhosis: still confusing after all these years? Hepatology; 38.